Cargando…
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
PURPOSE: Febrile neutropenia (FN) can cause suboptimal treatment and treatment-related mortality (TRM) in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). MATERIALS AND METHODS: We conducted a prospective co...
Autores principales: | Jeong, Seong Hyun, Kim, Seok Jin, Yoon, Dok Hyun, Park, Yong, Kang, Hye Jin, Koh, Youngil, Lee, Gyeong-Won, Lee, Won-Sik, Yang, Deok-Hwan, Do, Young Rok, Kim, Min Kyoung, Yoo, Kwai Han, Choi, Yoon Seok, Yun, Hwan Jung, Yi, Jun Ho, Jo, Jae-Cheol, Eom, Hyeon-Seok, Kwak, Jae-Yong, Shin, Ho-Jin, Park, Byeong Bae, Hyun, Shin Young, Yi, Seong Yoon, Kwon, Ji-Hyun, Oh, Sung Yong, Kim, Hyo Jung, Sohn, Byeong Seok, Won, Jong Ho, Kim, Se-Hyung, Lee, Ho-Sup, Suh, Cheolwon, Kim, Won Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582490/ https://www.ncbi.nlm.nih.gov/pubmed/34990525 http://dx.doi.org/10.4143/crt.2021.1168 |
Ejemplares similares
-
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
por: Yi, Jun Ho, et al.
Publicado: (2023) -
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
por: Cho, Hyungwoo, et al.
Publicado: (2023) -
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
por: Kim, Seok Jin, et al.
Publicado: (2023) -
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
por: Yhim, Ho-Young, et al.
Publicado: (2020) -
Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma
por: Shin, Junghoon, et al.
Publicado: (2019)